Martindale Pharmaceutical Company

Martindale Pharma is a leading UK-based specialty pharmaceutical company that focuses on the development, manufacture, and commercialization of essential medicines, particularly in the areas of addiction, critical care, and hospital specialty products. The company is a major supplier to the UK National Health Service (NHS) and maintains a significant international footprint, exporting products to over 50 countries. Martindale Pharma is well-regarded for its expertise in sterile injectables and its dominant position in the opioid substitution therapy market with brands like Physeptone. In 2017, the company was acquired by the French pharmaceutical group Ethypharm, creating a combined entity with a strong presence across European hospital and addiction markets. The company operates a large-scale manufacturing facility in Romford, UK, which provides both internal production and contract manufacturing services.